NP
BCAB icon

NorthRock Partners’s BioAtla BCAB Stock Holding History

NorthRock Partners’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-416
Closed -$14.3K – 653
2025
Q3 		$14.3K Buy
+416
New +$9.6K ﹤0.01% 869

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

NorthRock Partners's BCAB Position: Q4 2025 in Review

NorthRock Partners sold out of BioAtla (BCAB) in Q4 2025, closing a stake of 416 shares — an estimated $14.3K sold.

NorthRock Partners first reported a position in BCAB in Q3 2025 and held it in 1 quarter. The position peaked at $14.3K in Q3 2025. 41 funds tracked by Wall St. Rank hold BCAB as of Q4 2025.

  • NorthRock Partners reported no remaining BioAtla position as of Q4 2025 after selling out during the quarter.
  • NorthRock Partners sold 416 BioAtla shares in Q4 2025, an estimated $14.3K.
  • NorthRock Partners first reported a position in BioAtla in Q3 2025 and held it in 1 quarter.
  • NorthRock Partners's BioAtla position peaked at $14.3K in Q3 2025.
  • 41 funds tracked by Wall St. Rank held BioAtla as of Q4 2025.

Based on NorthRock Partners's 13F filing for Q4 2025, filed 17 Feb 2026.